Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 12:31 pm Sale | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 1,555,820 3.600% | -1,383,458 (-47.07%) | View |
| 2024-03-19 1:02 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 2,308,622 5.320% | 201,952 (+9.59%) | View |
| 2024-02-14 4:05 pm Sale | 13G | HAVARD BIOSCIENCE INC HBIO | Harvey Partners LLC | 2,557,500 6.000% | -354,000 (-12.16%) | View |
| 2024-02-14 09:00 am Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 2,918,034 6.800% | 153,995 (+5.57%) | View |
| 2024-02-14 08:46 am Sale | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 2,939,278 6.900% | -325,518 (-9.97%) | View |
| 2024-02-13 4:01 pm Sale | 13G | Harvard Apparatus Regenerative Technology Inc. HRGN | HARVARD BIOSCIENCE INC HBIO | 697,112 5.000% | -11,404 (-1.61%) | View |
| 2024-01-26 5:26 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 2,913,814 6.800% | 1,704,695 (+140.99%) | View |
| 2024-01-22 10:55 am Sale | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 2,106,670 4.940% | -52,124 (-2.41%) | View |
| 2023-08-28 3:07 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 2,158,794 5.060% | 104,887 (+5.11%) | View |
| 2023-02-16 3:11 pm Unchanged | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 3,264,796 7.800% | 0 (Unchanged) | View |
| 2023-02-15 5:30 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 3,264,796 7.840% | 3,264,796 (New Position) | View |
| 2023-02-14 4:05 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | Harvey Partners LLC | 2,911,500 7.000% | 2,911,500 (New Position) | View |
| 2023-02-13 5:12 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 2,764,039 6.640% | 597,264 (+27.56%) | View |
| 2023-02-13 3:55 pm Sale | 13G | HAVARD BIOSCIENCE INC HBIO | Portolan Capital Management LLC | 1,054,300 2.530% | -1,484,499 (-58.47%) | View |
| 2023-01-11 1:30 pm Sale | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 2,053,907 4.930% | -200,000 (-8.87%) | View |
| 2022-12-21 4:20 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 2,253,907 5.410% | 2,253,907 (New Position) | View |
| 2022-07-08 4:57 pm Sale | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 1,209,119 2.900% | -1,854,071 (-60.53%) | View |
| 2022-06-21 4:01 pm Purchase | 13G | Harvard Apparatus Regenerative Technology Inc. HRGN | HARVARD BIOSCIENCE INC HBIO | 708,516 5.800% | 708,516 (New Position) | View |
| 2022-02-14 11:02 am Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 2,166,775 5.310% | 2,166,775 (New Position) | View |
| 2022-02-11 2:01 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | Portolan Capital Management LLC | 2,538,799 6.220% | 473,154 (+22.91%) | View |